Neurol. praxi. 2021;22(3):218-224 | DOI: 10.36290/neu.2021.036

Prophylactic treatment of migraine and the most common mistakes

MUDr. Babeta Hofericová
Neurologická klinika JLF UK a Univerzitná nemocnica Martin

Migraine is the most common type of primary headaches encountered in neurological practice. This article provides the overview of current diagnostic criteria for the most common types of migraine, a brief up to date summary of acute treatment, but it is mainly focused on prophylactic treatment of more severe forms of migraine - choosing a suitable prophylactic drug, optimal timing of initiation, termination of treatment and highlighting the most common types of mistakes in treatment.

Keywords: migraine, episodic migraine, chronic migraine, prophylactic treatment.

Received: May 5, 2021; Revised: May 15, 2021; Accepted: May 15, 2021; Prepublished online: May 15, 2021; Published: October 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hofericová B. Prophylactic treatment of migraine and the most common mistakes. Neurol. praxi. 2021;22(3):218-224. doi: 10.36290/neu.2021.036.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Headache Society. The American Headache Society Position Statement on Integrating New Migraine Treatments into Clinical Practice. Headache. 2019; 59(1): 1-18. Go to original source... Go to PubMed...
    2. Diener HCH, Holle-Lee D, Nagel S, Dresler T, Gaul C, Göbel H, Heinze-Kuhn K, Jürgens T, Kropp P, Meyer B, May A, Schulte L, Solbach K, Straube A, Kamm K, Förderreuther S, Gantenbein A, Petersen J, Sandor P, Lampl C. Treatment of migraine attacks and prevention of migraine: Guidelines by the German Migraine and Headache Society and the German Society of neurology. Clinical and Translational Neuroscience 2019: 1-40. Go to original source...
    3. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Eur J Neurol 2009; 16(9): 968-981. Go to original source... Go to PubMed...
    4. Ha H, Gonzalez A. Migraine Headache Prophylaxis. Am Fam Physician 2019; 99(1): 17-24. Go to PubMed...
    5. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38(1): 1-211. Go to original source...
    6. Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia 2015; 35(6): 478-488. Go to original source... Go to PubMed...
    7. Marková J. Migréna. Cesk Slov Neurol N 2009; 72/105(3): 207-215.
    8. Ministerstvo zdravotníctva SR. Zoznam kategorizovaných liekov 1. 4. 2021-30. 4. 2021. Časť B: Indikačné obmedzenia. Dostupné na: https://www.health.gov.sk/Clanok?lieky202101.
    9. Monteith T. Chronic Migraine: Epidemiology, Mechanisms, and Treatment: A Comprehensive Guide to Evaluation and Management. 2019. doi: 10.1007/978-3-319-91491-6_4. Go to original source...
    10. Nežádal T, Marková J, Bártková A, Klečka L. CGRP monoklonální protilátky v léčbě migrény - indikační kritéria a terapeutická doporučení pro Českou republiku. Cesk Slov Neurol N 2020; 83/116(4): 445-451. Go to original source...
    11. Nežádal T. Migréna - současné možnosti terapie. Bolesť 2020; 23(1): 12-20.
    12. Niedermayerová I. Nejčastejší chyby v současné profylaxi migrény. Neurol. praxi 2020; 21(5): 400-405. Go to original source...
    13. Sacco S, Bendtsen L, Ashina M, Reuter U, Terwindt G, Mitsikostas DD, Martelletti P. European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention [published correction appears in J Headache Pain 2019; 20(1): 58. J Headache Pain 2019; 20(1): 6. Go to original source... Go to PubMed...
    14. Steiner TJ, Paemeleire K, Jensen R, Valade D, Savi L, Lainez MJ, Diener HC, Martelletti P, Couturier EG. European principles of management of common headache disorders in primary care. J Headache Pain 2007; 8(Suppl 1): S3-S47. doi: 10.1007/s10194-007-0366-y. Go to original source...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.